Ducommun Announces First Quarter Conference Call
Apr 24, 2017 11:01 am UTC| Business
LOS ANGELES, April 24, 2017 -- Ducommun Incorporated (NYSE:DCO) (“Ducommun” or the “Company”) today announced that it plans to release the Company's 2017 first quarter financial results after the market closes on...
Mammoth Energy Announces 1Q 2017 Earnings Release and Conference Call Schedule
Apr 24, 2017 11:01 am UTC| Business
OKLAHOMA CITY, April 24, 2017 -- Mammoth Energy Services, Inc. (“Mammoth”) (NASDAQ:TUSK) today announced that it will release financial results for the first quarter of 2017 after the market close on Wednesday, May 3,...
Mammoth Energy Announces 1Q 2017 Earnings Release and Conference Call Schedule
Apr 24, 2017 11:01 am UTC| Business
OKLAHOMA CITY, April 24, 2017 -- Mammoth Energy Services, Inc. (“Mammoth”) (NASDAQ:TUSK) today announced that it will release financial results for the first quarter of 2017 after the market close on Wednesday, May 3,...
Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs
Apr 24, 2017 11:01 am UTC| Business
PHOENIX, April 24, 2017 -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") announced that effective today, Dr. Steven James will join the Company as Vice President of Medical Affairs. “Dr. James...
Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs
Apr 24, 2017 11:01 am UTC| Business
PHOENIX, April 24, 2017 -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("Insys" or "the Company") announced that effective today, Dr. Steven James will join the Company as Vice President of Medical Affairs. “Dr. James...
Apr 24, 2017 11:01 am UTC| Business
BOSTON, April 24, 2017 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today...
Apr 24, 2017 11:01 am UTC| Business
BOSTON, April 24, 2017 -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry, today...